Ata Ch Diagnosis Algorithm

---
name: ata-ch-diagnosis-algorithm
description: This skill confirms central hypothyroidism when serum free T4 is below the laboratory reference range with low, normal, or mildly elevated TSH in the setting of pituitary disease. Use when assessing thyroid function in pituitary disease; triggers include pituitary disease with suspected thyroid dysfunction.
---

# Diagnose central hypothyroidism using fT4 and TSH

## STEP 1 — Gather Information
Collect serum free T4 (fT4), TSH, and confirm presence of known pituitary disease (e.g., adenoma, post-surgery, radiation). Also note symptoms suggestive of hypothyroidism.

## STEP 2 — Rule In / Rule Out
If fT4 is below the laboratory reference range AND TSH is low, normal, or mildly elevated AND pituitary disease is present → Rule in CH. Otherwise → Rule out CH (consider primary thyroid disease or non-thyroidal illness).

## STEP 3 — Classify or Stratify
For ruled-in cases: if fT4 is below reference range → classify as overt CH. If fT4 is within reference range but at the low‑normal end (low‑normal fT4) in pituitary disease → classify as suspected mild CH.

## STEP 4 — Decide
Overt CH: initiate levothyroxine (L‑T4) replacement targeting mid‑to‑upper reference fT4. Suspected mild CH: if symptomatic, start L‑T4; if asymptomatic, repeat fT4 in 3–6 months and treat if fT4 falls ≥20% from baseline.

## Clinical Guardrails / Mimics / Pitfalls
Do not rely on TSH alone to diagnose or monitor CH; avoid dynamic TSH‑secretion testing; ensure pituitary disease context is present; remember assay variability may affect low‑normal fT4 interpretation; do not adjust L‑T4 dose based on TSH in CH.

## Concrete Clinical Example
A 48‑year‑old man with a resected nonfunctioning pituitary adenoma has fT4 0.7 ng/dl (reference 0.9‑1.7) and TSH 1.5 µIU/ml (reference 0.4‑4.0). He reports fatigue and cold intolerance. fT4 below range with normal TSH in pituitary disease → overt CH → start L‑T4 1.6 µg/kg/d.

**Source:** Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118